Comparing the current results to its competitors, Akumin Inc reported Revenue decrease in the 3 quarter 2023 year on year by -3.21 %, despite the revenue increase by the most of its competitors of 0.77 %, recorded in the same quarter.
Akumin Inc , slower than the average decrease reported by the company's competitors of -38.39 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -38.39 %
Quest Diagnostics Inc operates as a leading provider of clinical laboratory and diagnostic information services, catering to patients, healthcare professionals, hospitals, and pharmaceutical companies. The company generates revenue through a comprehensive suite of diagnostic testing services, encompassing routine lab tests, advanced molecular diagnostics, and a variety of specialized tests tailored to support clinical decision-making and patient care.
iSpecimen Inc's business model revolves around connecting researchers with the biospecimens they need for their scientific and medical studies. They serve as an intermediary platform that links healthcare organizations and biobanks to the research community, providing a streamlined process for sourcing human biosamples and associated data.
Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.
Radnet Inc is a medical diagnostic imaging company that operates a network of outpatient imaging centers. Their business model focuses on offering convenient and accessible imaging services to patients, partnering with healthcare providers, and leveraging technology to ensure efficient operations. By providing advanced diagnostic capabilities and collaborating with insurance companies, Radnet Inc aims to enhance patient care and streamline the imaging process.
Sources:
Akumin Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Akumin Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
